AVATROMBOPAG

AVATROMBOPAG was reported 2368 times

AVATROMBOPAG is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SPLENOSIS 5 0.2778
1 PANCREATIC PSEUDOANEURYSM 4 0.2105
2 SECONDARY THROMBOCYTOSIS 1 0.0526
3 PENETRATING AORTIC ULCER 1 0.0213
4 RESTENOSIS 1 0.0172
5 GALLBLADDER EMPYEMA 1 0.0135
6 IMMUNE EFFECTOR CELL-ASSOCIATED HAEMATOTOXICITY 2 0.0115
7 MIDDLE CEREBRAL ARTERY STROKE 1 0.0088
8 BONE MARROW RETICULIN FIBROSIS 2 0.0078
9 AORTIC INTRAMURAL HAEMATOMA 1 0.0077
10 HAEMOPERITONEUM 6 0.0075
11 OVARIAN DISORDER 6 0.0064
12 IMMUNE THROMBOCYTOPENIA 23 0.0050
13 BULLOUS HAEMORRHAGIC DERMATOSIS 1 0.0048
14 MYELOFIBROSIS 14 0.0046
15 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA 2 0.0043
16 DEPENDENCE ON OXYGEN THERAPY 2 0.0041
17 EVANS SYNDROME 2 0.0041
18 BURNING FEET SYNDROME 1 0.0040
19 MUCOSAL HAEMORRHAGE 4 0.0034
20 ENTEROBACTER BACTERAEMIA 1 0.0033
21 THROMBOCYTOSIS 12 0.0033
22 CHRONIC HEPATITIS B 1 0.0032
23 RENAL VEIN THROMBOSIS 2 0.0030
24 ENTEROSTOMY 1 0.0029
25 RHINOCEREBRAL MUCORMYCOSIS 1 0.0029
26 STAB WOUND 1 0.0028
27 ERYTHROMELALGIA 1 0.0027
28 STEROID DIABETES 4 0.0027
29 HYPOPROTEINAEMIA 5 0.0026
30 SPLENECTOMY 3 0.0026
31 ANTIPHOSPHOLIPID SYNDROME 4 0.0025
32 CEREBRAL VENOUS SINUS THROMBOSIS 2 0.0024
33 PERIOSTITIS 1 0.0023
34 PLATELET COUNT ABNORMAL 14 0.0023
35 INFECTIOUS PLEURAL EFFUSION 3 0.0020
36 SPLENIC HAEMORRHAGE 1 0.0020
37 HYPERMETABOLISM 1 0.0019
38 CEREBRAL ARTERY OCCLUSION 2 0.0019
39 HAEMORRHAGIC INFARCTION 1 0.0018
40 MECHANICAL ILEUS 1 0.0018
41 AORTIC THROMBOSIS 2 0.0017
42 PLATELET COUNT 1 0.0017
43 ANTIPHOSPHOLIPID ANTIBODIES POSITIVE 1 0.0017
44 BLOOD LACTATE DEHYDROGENASE ABNORMAL 1 0.0015
45 SUPERIOR SAGITTAL SINUS THROMBOSIS 1 0.0013
46 CAROTID ARTERY THROMBOSIS 1 0.0012
47 PETECHIAE 12 0.0011
48 OROPHARYNGEAL CANDIDIASIS 1 0.0011
49 CEREBRAL VENOUS THROMBOSIS 2 0.0011
50 VASOSPASM 1 0.0011
51 HEMIANOPIA 1 0.0010
52 HEAVY MENSTRUAL BLEEDING 9 0.0010
53 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
54 HAEMORRHAGIC DISORDER 1 0.0009
55 ACINETOBACTER INFECTION 1 0.0009
56 MYOCARDIAL INJURY 1 0.0009
57 ECCHYMOSIS 6 0.0009
58 PERIPHERAL EMBOLISM 1 0.0009
59 ISCHAEMIC CEREBRAL INFARCTION 1 0.0009
60 PNEUMOCYSTIS JIROVECII INFECTION 1 0.0008
61 CATHETER SITE HAEMORRHAGE 2 0.0008
62 LIP HAEMORRHAGE 1 0.0008
63 CARDIAC VENTRICULAR THROMBOSIS 1 0.0008
64 COUNTERFEIT PRODUCT ADMINISTERED 1 0.0008
65 HIRSUTISM 1 0.0008
66 EMBOLISM 6 0.0007
67 VIRAEMIA 1 0.0007
68 INTERMENSTRUAL BLEEDING 4 0.0007
69 PERIODONTAL DISEASE 1 0.0007
70 PLATELET COUNT INCREASED 9 0.0007
71 GASTRITIS HAEMORRHAGIC 1 0.0007
72 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
73 INHIBITORY DRUG INTERACTION 1 0.0006
74 ENTEROBACTER INFECTION 1 0.0006
75 ENTERITIS INFECTIOUS 1 0.0006
76 AUTOIMMUNE HAEMOLYTIC ANAEMIA 2 0.0006
77 THERAPY NON-RESPONDER 26 0.0006
78 AUTOIMMUNE HEPATITIS 4 0.0006
79 APLASTIC ANAEMIA 3 0.0006
80 SPLENIC INFARCTION 1 0.0006
81 GRAFT VERSUS HOST DISEASE 4 0.0006
82 UTERINE LEIOMYOMA 4 0.0005
83 HYPERCOAGULATION 1 0.0005
84 OPTIC ISCHAEMIC NEUROPATHY 2 0.0005
85 CYTOMEGALOVIRUS CHORIORETINITIS 1 0.0005
86 GINGIVAL BLEEDING 7 0.0005
87 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
88 VASCULAR OCCLUSION 1 0.0005
89 RADIATION PNEUMONITIS 1 0.0005
90 PERIODONTITIS 1 0.0005
91 POST PROCEDURAL HAEMORRHAGE 5 0.0004
92 PULMONARY INFARCTION 1 0.0004
93 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
94 LACUNAR INFARCTION 1 0.0004
95 SELF ESTEEM DECREASED 1 0.0004
96 TRANSPLANT FAILURE 1 0.0004
97 HEPATOMEGALY 4 0.0004
98 VENOOCCLUSIVE DISEASE 1 0.0004
99 PLATELET DISORDER 1 0.0004
100 APPENDICITIS PERFORATED 1 0.0004
101 ABDOMINAL INFECTION 1 0.0004
102 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
103 SUBDURAL HAEMORRHAGE 1 0.0004
104 LUNG CONSOLIDATION 1 0.0004
105 PULMONARY ALVEOLAR HAEMORRHAGE 2 0.0004
106 RETINAL VEIN OCCLUSION 1 0.0003
107 FIBULA FRACTURE 1 0.0003
108 ELECTROLYTE IMBALANCE 4 0.0003
109 COVID-19 PNEUMONIA 4 0.0003
110 BONE MARROW DISORDER 1 0.0003
111 CYTOPENIA 4 0.0003
112 PORTAL HYPERTENSION 1 0.0003
113 HEPATIC FUNCTION ABNORMAL 12 0.0003
114 PLATELET COUNT DECREASED 34 0.0003
115 NEUTROPHIL COUNT DECREASED 13 0.0003
116 EOSINOPHILIC PNEUMONIA 1 0.0003
117 ABDOMINAL ADHESIONS 1 0.0003
118 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
119 LOSS OF THERAPEUTIC RESPONSE 1 0.0003
120 PNEUMONIA VIRAL 1 0.0003
121 ACUTE RESPIRATORY FAILURE 6 0.0003
122 PORTAL VEIN THROMBOSIS 1 0.0003
123 CYTOKINE RELEASE SYNDROME 6 0.0003
124 TERMINAL STATE 2 0.0003
125 HEPATIC CYST 1 0.0003
126 HYPERTRANSAMINASAEMIA 2 0.0003
127 CAROTID ARTERY STENOSIS 1 0.0003
128 RIGHT VENTRICULAR FAILURE 2 0.0003
129 THROMBOPHLEBITIS 1 0.0003
130 JAUNDICE CHOLESTATIC 1 0.0003
131 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
132 MYELOSUPPRESSION 10 0.0003
133 CHRONIC GRAFT VERSUS HOST DISEASE 1 0.0003
134 CAROTID ARTERY OCCLUSION 1 0.0003
135 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
136 MATERNAL EXPOSURE TIMING UNSPECIFIED 1 0.0003
137 HYPOCALCAEMIA 5 0.0003
138 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
139 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
140 HAEMOLYSIS 2 0.0003
141 VIRAL LOAD INCREASED 1 0.0003
142 RHINOVIRUS INFECTION 1 0.0003
143 CARDIOPULMONARY FAILURE 1 0.0003
144 PULMONARY HAEMORRHAGE 2 0.0003
145 PROCEDURAL HAEMORRHAGE 1 0.0003
146 GINGIVAL PAIN 2 0.0003
147 LACTIC ACIDOSIS 8 0.0002
148 ACUTE MYOCARDIAL INFARCTION 7 0.0002
149 MELAENA 5 0.0002
150 GINGIVAL SWELLING 1 0.0002
151 CYTOMEGALOVIRUS INFECTION REACTIVATION 1 0.0002
152 DRUG ERUPTION 4 0.0002
153 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
154 GALLBLADDER DISORDER 4 0.0002
155 BRAIN NEOPLASM 2 0.0002
156 UROSEPSIS 2 0.0002
157 FLANK PAIN 2 0.0002
158 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
159 HAEMORRHAGE INTRACRANIAL 3 0.0002
160 BONE MARROW FAILURE 4 0.0002
161 SUBARACHNOID HAEMORRHAGE 2 0.0002
162 MACULAR OEDEMA 1 0.0002
163 NEPHROPATHY TOXIC 2 0.0002
164 INTERNAL HAEMORRHAGE 2 0.0002
165 EXERCISE TOLERANCE DECREASED 1 0.0002
166 HERPES VIRUS INFECTION 1 0.0002
167 BLOOD URIC ACID INCREASED 1 0.0002
168 HYPERTRIGLYCERIDAEMIA 1 0.0002
169 THROMBOCYTOPENIA 19 0.0002
170 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1 0.0002
171 ISCHAEMIC STROKE 3 0.0002
172 ENTERITIS 1 0.0002
173 HAEMOGLOBIN ABNORMAL 1 0.0002
174 ANGINA UNSTABLE 1 0.0002
175 OSTEONECROSIS 5 0.0002
176 HYPOGAMMAGLOBULINAEMIA 1 0.0002
177 PANCREATITIS 8 0.0002
178 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
179 PULMONARY EMBOLISM 14 0.0001
180 TREATMENT FAILURE 12 0.0001
181 PULMONARY HYPERTENSION 3 0.0001
182 RETINAL HAEMORRHAGE 1 0.0001
183 SUBDURAL HAEMATOMA 2 0.0001
184 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
185 PRODUCT PRESCRIBING ISSUE 3 0.0001
186 ASCITES 4 0.0001
187 HEPATOTOXICITY 3 0.0001
188 TROPONIN INCREASED 1 0.0001
189 THERAPY PARTIAL RESPONDER 2 0.0001
190 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
191 RENAL CYST 1 0.0001
192 METABOLIC ACIDOSIS 4 0.0001
193 DEEP VEIN THROMBOSIS 8 0.0001
194 HICCUPS 1 0.0001
195 ESCHERICHIA INFECTION 1 0.0001
196 ACUTE CORONARY SYNDROME 1 0.0001
197 FEBRILE NEUTROPENIA 8 0.0001
198 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
199 PSEUDOMONAS INFECTION 1 0.0001
200 IMMUNOSUPPRESSION 1 0.0001
201 PURPURA 1 0.0001
202 CARDIOTOXICITY 1 0.0001
203 CEREBRAL HAEMORRHAGE 4 0.0001
204 INFECTION 16 0.0001
205 LEUKOCYTOSIS 2 0.0001
206 TOOTHACHE 2 0.0001
207 PNEUMONIA BACTERIAL 1 0.0001
208 INCREASED TENDENCY TO BRUISE 1 0.0001
209 EPISTAXIS 8 0.0001
210 LIVER FUNCTION TEST ABNORMAL 3 0.0001
211 AUTOIMMUNE DISORDER 1 0.0001
212 INFLAMMATORY BOWEL DISEASE 1 0.0001
213 THROMBOSIS 8 0.0001
214 INFLUENZA LIKE ILLNESS 8 0.0001
215 VENTRICULAR EXTRASYSTOLES 1 0.0001
216 HAEMORRHAGE 10 0.0001
217 DRUG-INDUCED LIVER INJURY 3 0.0001
218 SUDDEN DEATH 1 0.0001
219 SEPTIC SHOCK 4 0.0001
220 PULMONARY THROMBOSIS 1 0.0001
221 VIRAL INFECTION 3 0.0001
222 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
223 INTESTINAL PERFORATION 1 0.0001
224 MYOCARDITIS 1 0.0001
225 BACTERAEMIA 1 0.0001
226 ENCEPHALOPATHY 2 0.0001
227 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
228 HAEMATOMA 2 0.0001
229 RESPIRATORY TRACT INFECTION 2 0.0001
230 OFF LABEL USE 67 0.0001
231 QUALITY OF LIFE DECREASED 1 0.0001
232 CORONARY ARTERY OCCLUSION 1 0.0001
233 HAEMOPTYSIS 2 0.0001
234 COORDINATION ABNORMAL 1 0.0001
235 BLOOD TEST ABNORMAL 1 0.0001
236 PAIN IN JAW 2 0.0001
237 HEPATOCELLULAR INJURY 1 0.0001
238 MYELODYSPLASTIC SYNDROME 1 0.0001
239 SKIN HAEMORRHAGE 1 0.0001
240 IMMUNODEFICIENCY 1 0.0001
241 UNEVALUABLE EVENT 5 0.0001
242 INSURANCE ISSUE 1 0.0001
243 HYPOKALAEMIA 3 0.0001
244 CEREBROVASCULAR ACCIDENT 11 0.0001
245 MUSCULOSKELETAL CHEST PAIN 1 0.0001
246 WHITE BLOOD CELL COUNT DECREASED 7 0.0001
247 ACUTE MYELOID LEUKAEMIA 1 0.0001
248 DRUG INTERACTION 10 0.0001
249 ABSCESS 1 0.0001
250 ABDOMINAL PAIN 14 0.0001
251 CYTOMEGALOVIRUS INFECTION 1 0.0001
252 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
253 FLUID RETENTION 3 0.0001
254 ANAEMIA 11 0.0001
255 RASH MACULAR 2 0.0001
256 COVID-19 10 0.0001
257 GOUT 1 0.0001
258 RESTLESS LEGS SYNDROME 1 0.0001
259 AGRANULOCYTOSIS 1 0.0001
260 PANCYTOPENIA 3 0.0001
261 HEPATIC CIRRHOSIS 1 0.0001
262 DYSARTHRIA 2 0.0001
263 DYSPNOEA EXERTIONAL 2 0.0001
264 FRACTURE 1 0.0001
265 INCREASED APPETITE 1 0.0001
266 CONTUSION 5 0.0001
267 NEUTROPENIA 7 0.0001
268 CARDIO-RESPIRATORY ARREST 2 0.0000
269 LIVER FUNCTION TEST INCREASED 1 0.0000
270 HYPOACUSIS 2 0.0000
271 PNEUMONIA 15 0.0000
272 RASH MACULO-PAPULAR 1 0.0000
273 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
274 CHROMATURIA 1 0.0000
275 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
276 DISEASE RECURRENCE 2 0.0000
277 RASH ERYTHEMATOUS 2 0.0000
278 RESPIRATORY FAILURE 3 0.0000
279 CEREBRAL INFARCTION 1 0.0000
280 AGEUSIA 1 0.0000
281 CELLULITIS 2 0.0000
282 HYPOPHAGIA 1 0.0000
283 ERECTILE DYSFUNCTION 1 0.0000
284 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
285 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
286 CARDIAC FAILURE 3 0.0000
287 SEPSIS 4 0.0000
288 DRUG INEFFECTIVE 46 0.0000
289 DYSSTASIA 1 0.0000
290 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
291 CORONARY ARTERY DISEASE 1 0.0000
292 EPILEPSY 1 0.0000
293 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
294 ADVERSE EVENT 3 0.0000
295 SWELLING FACE 2 0.0000
296 BLOOD CREATININE INCREASED 2 0.0000
297 STAPHYLOCOCCAL INFECTION 1 0.0000
298 FUNGAL INFECTION 1 0.0000
299 NEOPLASM MALIGNANT 2 0.0000
300 TYPE 2 DIABETES MELLITUS 1 0.0000
301 HEPATIC ENZYME INCREASED 2 0.0000
302 HAEMOGLOBIN DECREASED 3 0.0000
303 HAEMATURIA 1 0.0000
304 DELIRIUM 1 0.0000
305 HYPERKALAEMIA 1 0.0000
306 NO ADVERSE EVENT 5 0.0000
307 C-REACTIVE PROTEIN INCREASED 1 0.0000
308 HYPERGLYCAEMIA 1 0.0000
309 CONFUSIONAL STATE 4 0.0000
310 BLINDNESS 1 0.0000
311 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
312 ROAD TRAFFIC ACCIDENT 1 0.0000
313 RECTAL HAEMORRHAGE 1 0.0000
314 DIARRHOEA 15 0.0000
315 MENTAL DISORDER 1 0.0000
316 CONSTIPATION 5 0.0000
317 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
318 ADVERSE DRUG REACTION 2 0.0000
319 TINNITUS 1 0.0000
320 BACK PAIN 5 0.0000
321 COGNITIVE DISORDER 1 0.0000
322 DRUG INTOLERANCE 2 0.0000
323 HYPOGLYCAEMIA 1 0.0000
324 DYSPEPSIA 2 0.0000
325 LEUKOPENIA 1 0.0000
326 FLUSHING 2 0.0000
327 CHEST DISCOMFORT 2 0.0000
328 HEADACHE 12 0.0000
329 DEATH 16 0.0000
330 OEDEMA 1 0.0000
331 ANAPHYLACTIC REACTION 1 0.0000
332 BONE PAIN 1 0.0000
333 SURGERY 1 0.0000
334 ILL-DEFINED DISORDER 1 0.0000
335 CONDITION AGGRAVATED 5 0.0000
336 CHEST PAIN 3 0.0000
337 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
338 RHINORRHOEA 1 0.0000
339 INFUSION RELATED REACTION 1 0.0000
340 RENAL FAILURE 2 0.0000
341 BLOOD PRESSURE DECREASED 1 0.0000
342 FALL 5 0.0000
343 WEIGHT DECREASED 4 0.0000
344 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
345 THERAPY INTERRUPTED 1 0.0000
346 PAIN IN EXTREMITY 4 0.0000
347 HYPOAESTHESIA 2 0.0000
348 ASTHENIA 5 0.0000
349 CHRONIC KIDNEY DISEASE 1 0.0000
350 BLOOD PRESSURE INCREASED 2 0.0000
351 ACUTE KIDNEY INJURY 2 0.0000
352 HOSPITALISATION 2 0.0000
353 PARAESTHESIA 2 0.0000
354 CARDIAC ARREST 1 0.0000
355 RENAL IMPAIRMENT 1 0.0000
356 SKIN EXFOLIATION 1 0.0000
357 URINARY TRACT INFECTION 2 0.0000
358 RASH 5 0.0000
359 PRODUCT USE ISSUE 2 0.0000
360 VOMITING 5 0.0000
361 GAIT DISTURBANCE 2 0.0000
362 FATIGUE 8 0.0000
363 NAUSEA 8 0.0000
364 ABDOMINAL PAIN UPPER 2 0.0000
365 HYPERTENSION 2 0.0000
366 WEIGHT INCREASED 2 0.0000
367 SEIZURE 1 0.0000
368 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
369 OEDEMA PERIPHERAL 1 0.0000
370 HYPERHIDROSIS 1 0.0000
371 VISION BLURRED 1 0.0000
372 COUGH 2 0.0000
373 MALAISE 3 0.0000
374 PERIPHERAL SWELLING 1 0.0000
375 MYALGIA 1 0.0000
376 MYOCARDIAL INFARCTION 1 0.0000
377 NASOPHARYNGITIS 1 0.0000
378 HYPERSENSITIVITY 1 0.0000
379 BLOOD GLUCOSE INCREASED 1 0.0000
380 HYPOTENSION 1 0.0000
381 ARTHRALGIA 2 0.0000
382 DECREASED APPETITE 1 0.0000
383 FEELING ABNORMAL 1 0.0000
384 DIZZINESS 2 0.0000
385 DYSPNOEA 2 0.0000
386 ANXIETY 1 0.0000
387 PYREXIA 1 0.0000
388 PAIN 1 0.0000